Αρχική World News News digest – light-activated nanoparticles, Government’s obesity plans, tumour ‘glue’ and AI...

News digest – light-activated nanoparticles, Government’s obesity plans, tumour ‘glue’ and AI research fund

Scientists are developing light-activated nanoparticles to kill cancer cells Credit: Harry Gui on Unsplash  

With news about the coronavirus pandemic developing daily, we want to make sure everyone affected by cancer gets the information they need during this time. 

We’re pulling together the latest government and NHS health updates from across the UK in a separate blog post, which we’re updating regularly. 

New rare blood cancer treatment gets green light for NHS in England 

A new combined therapy with the drug brentuximab has been approved for adults with a rare type of fast-growing lymphoma. Clinical trial evidence suggests the treatment could give people with this type of blood cancer more time before their disease progresses. More on this in our news report 

Government announces new push to tackle obesity 

Boris Johnson is set to announce restrictions on multi-buy and similar price promotions on a range of foods high in fat, sugar or salt in a bid to tackle rising obesity in the UK, according to The Times (£) and Guardian. The announcement comes off the back of evidence showing that 40% of food spending goes on products on promotion. However, health campaigners have expressed their disappointment at the seeming lack of action on junk food marketing. According to the leaked documents, a 9pm watershed on junk food adverts is ‘not on the cards at this time’, although the plans may change in the coming weeks.

Light-activated nanoparticles target cancer 

Scientists have developed light-activated nanoparticles that kill skin cancer cells in mice. The treatment involves linking tiny particles to short pieces of RNA that inhibit the production of essential proteins that cancer cells need to survive. It’s early days yet, but scientists are hopeful that the light-activated technology can help to reduce side effects and make the treatment more targeted. Read more on this at New Atlas.   

Scientists discover how cellular ‘glue’ can disrupt division  

An excess of a protein that’s essential to cell division – PRC1 – has been linked to many types of cancer, including prostate, ovarian and breast. Now scientists have found that the protein acts as a glue during cell division, precisely controlling the speed at which DNA strands separate as a single cell divides. These findings could help to explain why too much or too little PRC1 disrupts the division process and can be linked to cancer developing. Full story at Technology Networks.

AI investment to help improve lung cancer diagnosis 

Earlier this month, the Government announced over £16 million pounds in research funding to help improve the diagnosis of cancer and other life-threatening diseases, with Cancer Research UK putting in £3 million. Some of that money will go towards an Oxford-led project to improve lung cancer diagnosis. The team hope to use artificial intelligence to combine clinical, imaging and molecular data and make lung cancer diagnosis more accurate. More on this at Digital Health 

Partnership to develop new custom antibodies for cancer research 

We’ve partnered with Abcam to develop custom antibodies that could facilitate cancer research. Dr John Baker at Abcam said: “We are proud to be working with Cancer Research UK to support their scientists and help them achieve their next breakthrough faster.” Find out more at Cambridge Independent

And finally…. 

Technology Networks reports on a new study that has taken a closer look at how tiny bubble-like structures called vesicles can help cancer cells spread. Scientists found that vesicles from cancer cells contained high levels of proteins with lipid molecules attached, which are associated with the spread of cancer. We’ve blogged before about how tumours spread.

Scarlett Sangster is a writer for PA Media Group

More on this topic



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

De qué manera el seguimiento de los síntomas mejora la atención oncológica

Se sabe bien que el tratamiento contra el cáncer genera efectos secundarios significativos. Por ejemplo, la quimioterapia puede causar caída del cabello, náuseas e...

Man Who Lost His Mother to Breast Cancer Opens Resource Center in Her Memory

After the death of a beloved parent, you can find yourself wanting to carry their legacy forward in their absence. One man in Ohio...

Navigating Cancer Survivorship as a Transgender or Non-Binary Person

Mal Malme (Mal or they/them) is a proud Boston-based theater artist, activist, writer, and health care clown. Mal is co-founder of Queer Soup Theater...

Sing Anyway

“Some days there won’t be a song in your heart. Sing anyway.” – Emory Austin I love this thought from Emory Austin. I am reminded...

Topotecan–Berzosertib Combination Shows Promise against Small Cell Lung Cancer

May 5, 2021, by NCI Staff A small clinical trial tested the combination of topotecan with the drug berzosertib, which inhibits a protein that helps repair...

Substantial Decrease in the Use of Minimally Invasive Surgery for Cervical Cancer

A group of US investigators found a substantial decrease in the use of minimally invasive surgery, robotic or laparoscopic, for cervical cancer after publication...